- $43.36bn
- $41.63bn
- $21.92bn
- 97
- 37
- 72
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,714 | 9,498 | 17,661 | 17,532 | 21,916 |
Cost of Revenue | |||||
Gross Profit | 1,890 | 2,733 | 4,420 | 5,992 | 7,505 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,313 | 9,516 | 17,500 | 18,156 | 22,194 |
Operating Profit | 400 | -18.8 | 161 | -625 | -279 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 378 | 216 | 157 | -565 | -29.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 375 | 213 | 159 | -553 | -21.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 375 | 213 | 166 | -541 | 9.77 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 375 | 213 | 166 | -541 | 9.77 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.316 | 0.842 | 0.717 | -0.085 | 1.12 |